Collectively, these findings indicate that perlecan DV/LG3 is neuroprotective following stroke, OGD, and Amyloid-β stressors, suggesting that perlecan and its fragments may also be neuroprotective to other CNS diseases and insults as well. Here, HSPG2 is linked to stroke disorder.